NEW HAVEN, Conn., Dec. 19, 2018 (GLOBE NEWSWIRE) — Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company developing and commercializing […]
Feature-Rich App Delivers Mission-Critical, Intuitive and Actionable Crop Intelligence for Improving Crop Yields and Enhancing Sustainability Efforts Using Any Mobile […]